Construction of an alpha toxin gene knockout mutant of Clostridium perfringens type A by use of a mobile group II intron

被引:113
作者
Chen, Y
McClane, BA
Fisher, DJ
Rood, JI
Gupta, P
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
[3] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia
关键词
D O I
10.1128/AEM.71.11.7542-7547.2005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In developing Clostridium perfringens as a safe vaccine vector, the alpha toxin gene (plc) in the bacterial chromosome must be permanently inactivated. Disrupting genes in C perfringens by traditional mutagenesis methods is very difficult. Therefore, we developed a new strategy using group 11 intron-based Target-Tron technology to inactivate the plc gene in C. perfringens ATCC 3624. Western blot analysis showed no production of alpha toxin protein in the culture supernatant of the plc mutant. Advantages of this technology, such as site specificity, relatively high frequency of insertion, and introduction of no antibiotic resistance genes into the chromosome, could facilitate construction of other C. perfringens mutants.
引用
收藏
页码:7542 / 7547
页数:6
相关论文
共 16 条
[1]   Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene [J].
Awad, MM ;
Ellemor, DM ;
Boyd, RL ;
Emmins, JJ ;
Rood, JI .
INFECTION AND IMMUNITY, 2001, 69 (12) :7904-7910
[2]   Use of a Clostridium perfringens vector to express high levels of SIV p27 protein for the development of an oral SIV vaccine [J].
Chen, Y ;
Helmus, R ;
McClane, B ;
Hoffman, R ;
Watkins, S ;
Wehrli, T ;
Gupta, P .
VIROLOGY, 2004, 329 (02) :226-233
[3]   Retrohoming of a bacterial group II intron: Mobility via complete reverse splicing, independent of homologous DNA recombination [J].
Cousineau, B ;
Smith, D ;
Lawrence-Cavanagh, S ;
Mueller, JE ;
Yang, J ;
Mills, D ;
Manias, D ;
Dunny, G ;
Lambowitz, AM ;
Belfort, M .
CELL, 1998, 94 (04) :451-462
[4]   Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C-perfringens [J].
Czeczulin, JR ;
Collie, RE ;
McClane, BA .
INFECTION AND IMMUNITY, 1996, 64 (08) :3301-3309
[5]   Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene [J].
Fisher, DJ ;
Miyamoto, K ;
Harrison, B ;
Akimoto, S ;
Sarker, MR ;
McClane, BA .
MOLECULAR MICROBIOLOGY, 2005, 56 (03) :747-762
[6]   Genetic manipulation of Lactococcus lactis by using targeted group II introns:: Generation of stable insertions without selection [J].
Frazier, CL ;
Filippo, JS ;
Lambowitz, AM ;
Mills, DA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (02) :1121-1128
[7]  
Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295
[8]   Group II introns designed to insert into therapeutically relevant DNA target sites in human cells [J].
Guo, HT ;
Karberg, M ;
Long, M ;
Jones, JP ;
Sullenger, B ;
Lambowitz, AM .
SCIENCE, 2000, 289 (5478) :452-457
[9]   Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria [J].
Karberg, M ;
Guo, HT ;
Zhong, J ;
Coon, R ;
Perutka, J ;
Lambowitz, AM .
NATURE BIOTECHNOLOGY, 2001, 19 (12) :1162-1167
[10]   Mobile group II introns [J].
Lambowitz, AM ;
Zirnmerly, S .
ANNUAL REVIEW OF GENETICS, 2004, 38 :1-35